Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Phase 2 Completed
355 enrolled 39 charts
A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis
Completed
2,207 enrolled 10 charts
A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL)
Phase 4 Completed
1 enrolled 1 chart
EVOLVE-IBERIA
Completed
409 enrolled 55 charts
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Completed
17,667 enrolled
GARDENIA
Phase 3 Completed
397 enrolled 32 charts
LAUREL
Phase 3 Completed
359 enrolled 34 charts
HICKORY
Phase 3 Completed
609 enrolled 52 charts
HIBISCUS I
Phase 3 Completed
358 enrolled 42 charts
HIBISCUS II
Phase 3 Completed
358 enrolled 38 charts
PACE
Phase 3 Completed
107 enrolled 18 charts
Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients
Completed
157 enrolled
A Study of Safety and Effectiveness of JNJ-54781532 in Patients With Moderately to Severely Active Ulcerative Colitis
Phase 2 Completed
219 enrolled
Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
Completed
1,731 enrolled
Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis
Phase 1 Completed
33 enrolled
RETROPRESS
Completed
171 enrolled
Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis
Phase 2 Completed
22 enrolled
Study of COLAL-PRED to Treat Moderate to Severe Ulcerative Colitis
Phase 2 Completed
190 enrolled